Log In
BCIQ
Print this Print this
 

SKL-DEP

  Manage Alerts
Collapse Summary General Information
Company SK Biopharmaceuticals Co. Ltd.
DescriptionSerotonin, norepinephrine and dopamine reuptake inhibitor (SNDRI)
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationDepression
Indication DetailsTreat depression
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today